What Concinnity Genetics say about themselves
“Concinnity designs unique RNA-based gene control systems that enable the precise control of gene therapies to improve safety.”
Concinnity Genetics Ltd
- Incorporated
- 17 October 2023 (3 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Graeme Charles FielderLiam Mark TaylorDavid Charles Venables
- Accounts type
- Small
- Region
- Scotland
- Address
- C/o Cms Cameron Mckenna Nabarro Olswang LLP 4th FloorSaltire Court20 Castle TerraceEdinburghEH1 2EN
Website & contact details
- Website
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 30 October 2027
- Last conf. stmt
- 16 October 2026
Officers 4 active
Officer details are public data from the Companies House register.
Fielder, Graeme Charles
Director · Appointed 18 July 2025
British
Born November 1984
Taylor, Liam Mark
Director · Appointed 11 July 2025
Australian
Born March 1977 (49)
Venables, David Charles, Dr
Director · Appointed 17 April 2024
British
Born December 1966 (59)
Birt, Jessica Charlotte
Director · Appointed 17 October 2023
British
Born September 1992 (34)
Officer history (1 former)
18 July 2025
Appointed Fielder, Graeme Charles as Director
11 July 2025
Appointed Taylor, Liam Mark as Director
8 November 2024
Resigned Dale, Matthew Peter as Director
17 April 2024
Appointed Venables, David Charles, Dr as Director
17 October 2023
Appointed Birt, Jessica Charlotte as Director
17 October 2023
Appointed Dale, Matthew Peter as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
13 November 2024
Ceased Matthew Peter Dale — Owns 25–50% of shares
13 November 2024
Ceased Jessica Charlotte Birt — Owns 25–50% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £2,717,924
- Cash
- £2,742,203
- Employees
- 2
Balance sheet detail
| 2024 | |
|---|---|
| Cash | £2,742,203 |
| Creditors (< 1 year) | £56,022 |
| Net Assets | £2,717,924 |
| Shareholder Funds | £2,717,924 |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Cambridge
Cambridge
Abingdon
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →